The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-021-06607-3.pdf
Reference100 articles.
1. Thorpe LM, Yuzugullu H, Zhao JJ (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15(1):7–24
2. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12(1):9–22
3. Menon S, Manning BD (2008) Common corruption of the mTOR signaling network in human tumors. Oncogene 27(2):S43–S51
4. Zaytseva YY et al (2012) mTOR inhibitors in cancer therapy. Cancer Lett 319(1):1–7
5. Pedroza DA et al (2020) Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling. Br J Cancer 123:1326–1335
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer;Chemico-Biological Interactions;2024-06
2. Hallmarks of cancer resistance;iScience;2024-06
3. A perspective on tumor radiation resistance following high-LET radiation treatment;Journal of Cancer Research and Clinical Oncology;2024-05-02
4. Knockdown of SETD5 Inhibits Colorectal Cancer Cell Growth and Stemness by Regulating PI3K/AKT/mTOR Pathway;Biochemical Genetics;2024-04-19
5. miR-141-3p Enhanced Radiosensitivity of CRC Cells;Combinatorial Chemistry & High Throughput Screening;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3